Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
2.020
+0.410 (25.47%)
At close: Mar 6, 2026, 4:00 PM EST
2.000
-0.020 (-0.99%)
After-hours: Mar 6, 2026, 7:59 PM EST
Pulmonx Employees
Pulmonx had 291 employees as of December 31, 2024. The number of employees increased by 12 or 4.30% compared to the previous year.
Employees
291
Change (1Y)
12
Growth (1Y)
4.30%
Revenue / Employee
$310,986
Profits / Employee
-$185,577
Market Cap
83.32M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 291 | 12 | 4.30% |
| Dec 31, 2023 | 279 | 10 | 3.72% |
| Dec 31, 2022 | 269 | 16 | 6.32% |
| Dec 31, 2021 | 253 | 33 | 15.00% |
| Dec 31, 2020 | 220 | 40 | 22.22% |
| Jun 30, 2020 | 202 | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Neuronetics | 716 |
| Treace Medical Concepts | 477 |
| Xtant Medical Holdings | 232 |
| Baird Medical Investment Holdings | 143 |
| MaxCyte | 114 |
| Hyperfine | 111 |
| Picard Medical | 75 |
| InspireMD | 66 |
LUNG News
- 2 days ago - Pulmonx Corporation (LUNG) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Pulmonx Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 2 days ago - Pulmonx Announces Closing of up to $60 Million Credit Facility - GlobeNewsWire
- 14 days ago - Pulmonx to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 - GlobeNewsWire
- 3 months ago - Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 months ago - Pulmonx Corporation (LUNG) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Pulmonx Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 4 months ago - Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025 - GlobeNewsWire